Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Lixisenatide (Adlyxin) Peptide
Short-acting GLP-1 agonist focused on postprandial glucose.
What is Lixisenatide (Adlyxin)?
Lixisenatide (Adlyxin) is a glp-1 agonist · metabolic peptide studied for type 2 diabetes and postprandial hyperglycemia. Below is an educational overview of Lixisenatide (Adlyxin) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Adlyxin
Type 2 diabetes — once-daily injection before the first meal.
A short-acting GLP-1 that mainly blunts after-meal blood sugar spikes.
- •Nausea
- •Vomiting
- •Headache
- •Diarrhea
- •Dizziness
- •Pancreatitis
- •Severe hypoglycemia with sulfonylureas/basal insulin
- •Allergic reactions including anaphylaxis
- •History of severe GI disease
- •Personal allergy to GLP-1 analogs
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Lixisenatide (Adlyxin) Mechanism of Action
Exendin-4 derivative with potent postprandial glucose-lowering effect via delayed gastric emptying and enhanced insulin response.
Lixisenatide (Adlyxin) Research Areas & Benefits
Lixisenatide (Adlyxin) Dosage & Common Research Protocols
10 mcg SC daily x14d, then 20 mcg daily.
Protocols summarized for educational reference from published research. Not dosing guidance.
Lixisenatide (Adlyxin) Studies & Cited Research
ELIXA trial
Cardiovascular safety in T2D patients post-ACS.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Lixisenatide (Adlyxin) Side Effects & Safety Considerations
- •FDA-approved.
- •GI side effects common.
Common questions about Lixisenatide (Adlyxin)
More Fat loss peptides · See all 14
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.